Ex-Date | Pay Date | Amount | Change |
---|---|---|---|
$0.1533 | |||
$0.1533 | -0.97% | ||
$0.6783 | 27.17% | ||
$0.1548 | -20.49% | ||
$0.1947 | 25.05% | ||
$0.1557 | -10% | ||
$0.173 | -0.8% | ||
$0.5334 | -20.58% | ||
$0.6716 | 52.98% | ||
$0.439 | 79.55% | ||
$0.2445 | -16.04% | ||
$0.2912 | 21.99% | ||
$0.2387 | -18.31% | ||
$0.2922 | 18.68% | ||
$0.2462 | -27.4% | ||
$0.3391 | -31.23% |
SPDR S&P Pharmaceuticals ETF pays a dividend yield (FWD) of 1.71%.
- ISIN
- WKN
- Symbol / Exchange
- / XNYS
- Value
- €33.78
- Dividend frequency
- quarterly
- Security Type
- ETF
- Dividend Currency
- US Dollar
- 2 Countries
United States
98.97%Singapore
1.03%
- 1 Sector
Health Care
100.00%
- 42 Holdings
- Within the last 12 months, SPDR S&P Pharmaceuticals ETF paid a dividend of $0.66. For the next 12 months, SPDR S&P Pharmaceuticals ETF is expected to pay a dividend of $0.66. This corresponds to a dividend yield of approximately 1.71%.
- The dividend yield of SPDR S&P Pharmaceuticals ETF is currently 1.71%.
- SPDR S&P Pharmaceuticals ETF pays quarterly dividends. This is paid in the months of June, September, December, March.
- The next dividend for SPDR S&P Pharmaceuticals ETF is expected in June.
- SPDR S&P Pharmaceuticals ETF paid dividend every year within the last 10 years.
- Dividends of $0.66 are expected for the next 12 months. This corresponds to a dividend yield of 1.71%.
- The largest sectors of SPDR S&P Pharmaceuticals ETF are Health Care.
- The last stock split of SPDR S&P Pharmaceuticals ETF was on 11 September 2015 in the ratio 2:1.
- To receive the last dividend of SPDR S&P Pharmaceuticals ETF on 26 March 2025 in the amount of $0.15 you had to have the stock in your portfolio before the ex-day on 24 March 2025.
- The last dividend was paid on 26 March 2025.
- In 2022, dividends of $0.67 were paid by SPDR S&P Pharmaceuticals ETF.
- Dividends from SPDR S&P Pharmaceuticals ETF are paid in US Dollar.
- In SPDR S&P Pharmaceuticals ETF, the United States and Singapore are represented as the two largest countries.